BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24265033)

  • 41. Geographical Disparities and Factors Associated With the Decision to Decline Chemotherapy in Breast Cancer.
    Jabbal IS; Bilani N; Yaghi M; Elson L; Liang H; Nahleh ZA
    JCO Oncol Pract; 2022 Sep; 18(9):e1417-e1426. PubMed ID: 35658495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient and peer: Guideline design and expert response.
    Greve J; Kristensen SR; Lydiksen N
    J Health Econ; 2023 Dec; 92():102806. PubMed ID: 37729841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Definitions, guidelines and opinions: the white, the black and the grey.
    Gattinoni L
    Intensive Care Med; 2024 Jun; 50(6):934-936. PubMed ID: 38709290
    [No Abstract]   [Full Text] [Related]  

  • 44. Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) Registries.
    Kish JK; Yu M; Percy-Laurry A; Altekruse SF
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):236-43. PubMed ID: 25417237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Healthcare Predictors of Information Dissemination About Genetic Risks.
    Henderson V; Strayhorn SM; Bergeron NQ; Strahan DC; Ganschow PS; Khanna AS; Watson K; Hoskins K; Molina Y
    Cancer Control; 2022; 29():10732748221104666. PubMed ID: 35658635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast Cancer Disparities Among Women in Underserved Communities in the USA.
    Thompson B; Hohl SD; Molina Y; Paskett ED; Fisher JL; Baltic RD; Washington CM
    Curr Breast Cancer Rep; 2018 Sep; 10(3):131-141. PubMed ID: 31501690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.
    Rauscher GH; Silva A; Pauls H; Frasor J; Bonini MG; Hoskins K
    Breast Cancer Res Treat; 2017 Jun; 163(2):321-330. PubMed ID: 28251385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns of 21-gene assay testing and chemotherapy use in black and white breast cancer patients.
    Sheppard VB; O'Neill SC; Dilawari A; Horton S; Hirpa FA; Isaacs C
    Clin Breast Cancer; 2015 Apr; 15(2):e83-92. PubMed ID: 25555816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center.
    Erickson BK; Martin JY; Shah MM; Straughn JM; Leath CA
    Gynecol Oncol; 2014 May; 133(2):142-6. PubMed ID: 24517876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines.
    Silva A; Rauscher GH; Hoskins K; Rao R; Ferrans CE
    Breast Cancer Res Treat; 2013 Dec; 142(3):667-72. PubMed ID: 24265033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System.
    Eaglehouse YL; Darcy KM; Tian C; Casablanca Y; Shriver CD; Zhu K
    Obstet Gynecol; 2021 Apr; 137(4):629-640. PubMed ID: 33706355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Race/ethnicity and disparities in mastectomy practice in the Breast Cancer Care in Chicago study.
    Dookeran KA; Silva A; Warnecke RB; Rauscher GH
    Ann Surg Oncol; 2015 Jan; 22(1):66-74. PubMed ID: 25135847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.
    Joslin CE; Brewer KC; Davis FG; Hoskins K; Peterson CE; Pauls HA
    Gynecol Oncol; 2014 Nov; 135(2):285-91. PubMed ID: 25173584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast cancer survival, survival disparities, and guideline-based treatment.
    Hill DA; Friend S; Lomo L; Wiggins C; Barry M; Prossnitz E; Royce M
    Breast Cancer Res Treat; 2018 Jul; 170(2):405-414. PubMed ID: 29569018
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.